Literature DB >> 19020939

Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.

Timothy M Pawlik1, Lia Assumpcao, Josephina A Vossen, Manon Buijs, Ana L Gleisner, Richard D Schulick, Michael A Choti.   

Abstract

Surgery is the treatment of choice in selected patients with hepatic colorectal metastases. Despite improvements in preoperative imaging, patients can undergo unnecessary nontherapeutic laparotomy. The aim of this study was to examine trends in nontherapeutic laparotomy rates in patients undergoing planned surgical therapy for hepatic colorectal metastases. Data from 530 operations (461 patients) undergoing potentially curative surgical therapy for colorectal liver metastases between 1994 and 2005 were analyzed. The incidence of nontherapeutic laparotomy was determined and factors associated with nontherapeutic laparotomy were identified. Overall, 49 nontherapeutic laparotomies were performed (9.2%). Higher nontherapeutic laparotomy rates were seen in patients with multiple metastases and tumor size >5 cm (both P < 0.05). Preoperative positron emission tomography (PET) imaging was associated with lower risk of nontherapeutic laparotomy [5.6% versus 12.4%, P = 0.009, odds ratio (OR) = 0.42]. At laparotomy, extrahepatic findings were the reason for nontherapeutic laparotomy in 44.9% of cases. The nontherapeutic laparotomy rate significantly decreased over time (14.9% for 1994-1997 versus 9.6% for 1998-2001 versus 4.7% for 2002-2005; P = 0.003). While patients in each time period were similar with regard to tumor specific factors, utilization of PET imaging (P < 0.001) as well as resection plus ablation (P = 0.004) increased over time. We conclude that prevalence of nontherapeutic laparotomy for patients undergoing surgical exploration for hepatic colorectal metastases has decreased significantly in recent years to less than 5%. The reasons for this trend are probably multifactorial and may include improved preoperative assessment, such as PET imaging, as well as salvage surgical options.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020939     DOI: 10.1245/s10434-008-0230-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Colorectal liver metastases with extrahepatic disease--a new criteria for oncologic resection?

Authors:  Terence C Chua; David L Morris
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Multicentre study of liver metastases from colorectal cancer in pathological livers.

Authors:  Jose M Ramia; Rafael López-Andujar; Jaume Torras; Laia Falgueras; Jose Antonio Gonzalez; Belinda Sanchez; Joan Figueras
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

3.  Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factors.

Authors:  Konrad Mohnike; Steffen Wolf; Robert Damm; Max Seidensticker; Ricarda Seidensticker; Frank Fischbach; Nils Peters; Peter Hass; Günther Gademann; Maciej Pech; Jens Ricke
Journal:  Strahlenther Onkol       Date:  2016-02-29       Impact factor: 3.621

Review 4.  The role of local therapy in the management of lung and liver oligometastases.

Authors:  Simon S Lo; Susan D Moffatt-Bruce; Laura A Dawson; Roderich E Schwarz; Bin S Teh; Nina A Mayr; Jiade J Lu; John C Grecula; Thomas E Olencki; Robert D Timmerman
Journal:  Nat Rev Clin Oncol       Date:  2011-05-24       Impact factor: 66.675

5.  Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.

Authors:  Eddie K Abdalla; Todd W Bauer; Yun S Chun; Michael D'Angelica; David A Kooby; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

6.  Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.

Authors:  Skye C Mayo; Jennifer E Heckman; Andrew D Shore; Hari Nathan; Alexander A Parikh; John F P Bridges; Robert A Anders; Daniel A Anaya; Natasha S Becker; Timothy M Pawlik
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

7.  Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.

Authors:  Srinevas K Reddy; Michael W Kattan; Changhong Yu; Eugene P Ceppa; Sebastian G de la Fuente; Yuman Fong; Bryan M Clary; Rebekah R White
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

8.  Resection of colorectal liver metastases.

Authors:  Eddie K Abdalla
Journal:  J Gastrointest Surg       Date:  2011-02-08       Impact factor: 3.452

Review 9.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

10.  In colorectal liver metastases, the presence of extrahepatic disease correlates with the pathology of the primary tumour.

Authors:  Saleh Abbas; Vincent Lam
Journal:  ISRN Oncol       Date:  2011-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.